Thromboembolic disease in pregnancy

Current Opinion in Obstetrics and Gynecology

Volumn 12, Issue 2, 2000, Pages 117-122

  Gates, S ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ALLERGIC REACTION; ARTICLE; BLEEDING; CLINICAL TRIAL; DISEASE ASSOCIATION; FETUS WASTAGE; GENE MUTATION; HEMOPHILIA; HUMAN; INCIDENCE; OSTEOPOROSIS; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; RISK; SIDE EFFECT; THROMBOCYTOPENIA; THROMBOEMBOLISM;

FEMALE; FETAL DEATH; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RISK FACTORS; THROMBOEMBOLISM;

EID: 0034463178     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-200004000-00010     Document Type: Article

References (43)

1. Maternal mortality in Sweden, 1980-1988
2. Pregnancy-related mortality in the United States, 1987-1990
3. Late venous function in the leg after deep venous thrombosis occurring in relation to pregnancy
4. Long term outcome of patients with venous thromboembolism during pregnancy
5. Current concepts of anticoagulant therapy in pregnancy
6. Can more be done in obstetric and gynecologic practice to reduce morbidity and mortality associated with venous thromboembolism?
7. Thrombosis in pregnancy: Maternal and fetal issues
8. Thrombotic risk during pregnancy: A population study
9. Incidence, clinicial characteristics and timing of objectively diagnosed venous thromboembolism during pregnancy
10. Venous thromboembolic disease in obstetrics and gynaecology: The Scottish experience
11. The role of inherited thrombophilia in venous thromboembolism asociated with pregnancy
12. Risk factors for pregnancy associated venous thromboembolism
13. Deep vein thrombosis during pregnancy and the puerperium: A meta-analysis of the period of risk and the leg of presentation
14. Venous thrombosis: A multicausal disease
15. Genetic susceptibility to pregnancy-related venous thromboembolism: Roles of factor V Leiden, prothrombin G20210A and methylenetetrahydrofolate reductase C677T mutations
16. Thrombosis and pregnancy in congenital deficiencies an AT III, protein C or protein S deficiency: Study of 78 women
17. Activated protein C resistance (FV: Q506) and pregnancy
18. Hazards of heparin: Bleeding, allergy, heparin-induced thrombocytopenia, osteoporosis
19. Low molecular weight heparin for obstetric thromboprophylaxis
20. Safety of low molecular weight heparin in pregnancy: A systematic review
21. The risks of subcutaneous heparin prophylaxis: A controlled trial
22. Effect of low dose heparin on blood loss at caesarean section
23. Die perioperative thromboseprophylaxe beim kaiseschnitt: Ergebnisse einer randomisierten prospektiven vergleichsuntersuohung mit 6% hydroxyäthylstärke 0, 62 und low-dose-heparin
24. Thromboembolieprophylaxe mit niedermolekularem heparin (Fragmin) in der geburtshilfe
25. Low-molecular weight heparin is associated with less peripartum blood loss than unfractionated heparin
26. Prevention of venous thrombosis and pulmonary embolism
27. Thrombophilia-associated pregnancy wastage
28. Increased risk for fetal loss in carriers of the factor V Leiden mutation
29. Increased frequency of genetic thrombophilia in women with complications of pregnancy
30. Thrombophilic mutations are common in women with fetal loss without apparent cause
31. Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent - The Nimes Obstetricians and Haemotologists Study 5 (NOHA5)
32. Activated protein C resistance and Factor V Leiden in patients with hemolysis, elevated liver enzymes, low platelets syndrome
33. Resistance to activated protein C and the Leiden mutation: High prevalence in patients with abruptio placentae
34. Factor V Q506 mutation (activated protein C resistance) associated with reduced intrapartum blood loss - A possible evolutionary selection mechanism
35. A mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta
36. Activated protein C resistance can be associated with recurrent fetal loss
37. Randomized controlled trial of aspirin and aspirin plus heparinin pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
38. Antiphospholipid antibody associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone
39. Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: A preliminary study
40. Inherited thrombophilia and adverse pregnancy outcome: Has the time come for selective testing?